PRIMARY VECTOR
SYSTEMIC OPTIMIZATION
CLINICAL EFFICACY
DATA PENDING CLINICAL REVIEW
NCBI VERIFICATION
AWAITING PUBMED INDEX
WHAT IS IT?
An FDA-approved macrolide compound and immunosuppressant originally used for organ transplant patients.
WHAT DOES IT DO?
Inhibits the mTOR pathway, tricking the body into a fasted state to trigger deep cellular autophagy.
HOW DO I USE IT?
Taken off-label in strict, pulsed oral doses (typically 5-8mg once per week) to trigger autophagy.
DEPLOYED BY OPERATORSHEALTHTRENDS SCORE™
01Bryan Johnson
99.002Peter Attia
98.003David Sinclair
97.005Tim Ferriss
95.0